Glycine receptors in CNS neurons as a target for nonretrograde action of cannabinoids

Journal of Neuroscience

Volumn 25, Issue 33, 2005, Pages 7499-7506

  Lozovaya, Natalia ^a   Yatsenko, Natalia ^a   Beketov, Andrey ^a   Tsintsadze, Timur ^a   Burnashev, Nail ^b,c  

^a BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Cannabinoids; Cerebellum; Desensitization; Glycine receptor; Hippocampus; Seizure like activity

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; ANANDAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; CANNABINOID 3 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CAPSAZEPINE; ENDOCANNABINOID; G PROTEIN COUPLED RECEPTOR; GINKGOLIDE B; GINKGOLIDE J; GLYCINE RECEPTOR; RIMONABANT; STRYCHNINE; UNCLASSIFIED DRUG;

AMPLITUDE MODULATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DESENSITIZATION; DRUG MECHANISM; ELECTRIC POTENTIAL; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; PYRAMIDAL NERVE CELL; RAT; RECEPTOR BINDING; TIME;

ANIMALS; CENTRAL NERVOUS SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCANNABINOIDS; NEURAL INHIBITION; NEURONS; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; RECEPTORS, GLYCINE;

EID: 23844464052     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0977-05.2005     Document Type: Article

References (69)

1. Adams IB, Compton DR, Martin BR (1998) Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. J Pharmacol Exp Ther 284:1209-1217.
2. Akaike N, Kaneda M (1989) Glycine-gated chloride current in acutely isolated rat hypothalamic neurons. J Neurophysiol 62:1400-1409.
3. Alger BE, Nicoll RA (1979) GABA-mediated biphasic inhibitory responses in hippocampus. Nature 281:315-317.
4. Ameri A, Wilhelm A, Simmet T (1999) Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. Br J Pharmacol 126:1831-1839.
5. Aprison MH (1990) The discovery of the neurotransmitter role of glycine. In: Glycine transmission (Ottersen OP, Storm-Mathisen J, eds), pp 1-24. New York: Wiley.
6. Awatramani GB, Turecek R, Trussell LO (2004) Inhibitory control at a synaptic relay. J Neurosci 24:2643-2647.
7. Backus KH, Deitmer JW, Friauf E (1998) Glycine-activated currents are changed by coincident membrane depolarization in developing rat auditory brainstem neurones. J Physiol (Lond) 507:783-794.
8. Baskfield CY, Martin BR, Wiley JL (2004) Differential effects of delta9-tetrahydrocannabinol and methanandamide in CB1 knockout and wild-type mice. J Pharmacol Exp Ther 309:86-91.
9. Bormann J, Hamill OP, Sakmann B (1987) Mechanism of anion permeation through channels gated by glycine and gamma-aminobutyric acid in mouse cultured spinal neurones. J Physiol (Lond) 385:243-286.
10. Brackmann M, Zhao C, Schmieden V, Braunewell KH (2004) Cellular and subcellular localization of the inhibitory glycine receptor in hippocampal neurons. Biochem Biophys Res Commun 324:1137-1142.
11. Burger PM, Hell J, Mehl E, Krasel C, Lottspeich F, Jahn R (1991) GABA and glycine in synaptic vesicles: storage and transport characteristics. Neuron 7:287-293.
12. Casseday JH, Ehrlich D, Covey E (2000) Neural measurement of sound duration: control by excitatory-inhibitory interactions in the inferior colliculus. J Neurophysiol 84:1475-1487.
13. Chattipakorn SC, McMahon LL (2002) Pharmacological characterization of glycine-gated chloride currents recorded in rat hippocampal slices. J Neurophysiol 87:1515-1525.
14. Chattipakorn SC, McMahon LL (2003) Strychnine-sensitive glycine receptors depress hyperexcitability in rat dentate gyrus. J Neurophysiol 89:1339-1342.
15. Cherubini E, Bernardi G, Stanzione P, Marciani MG, Mercuri N (1981) The action of glycine on rat epileptic foci. Neurosci Lett 21:93-97.
16. A receptor-mediated IPSCs in identified lamina 1 neurons of the adult rat spinal cord. J Neurosci 19:7342-7355.
17. Chevaleyre V, Castillo PE (2004) Endocannabinoid-mediated metaplasticity in the hippocampus. Neuron 43:871-881.
18. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949.
19. Diana MA, Levenes C, MacKie K, Marty A (2002) Short-term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids. J Neurosci 22:200-208.
20. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372:686-691.
21. A receptor-mediated chloride fluxes in synaptoneurosomes from different parts of the rat brain. Brain Res 712:74-83.
22. Fricker D, Miles R (2000) EPSP amplification and the precision of spike timing in hippocampal neurons. Neuron 28:559-569.
23. Galarreta M, Hestrin S (2001) Spike transmission and synchrony detection in networks of GABAergic interneurons. Science 292:2295-2299.
24. Geiger JR, Lubke J, Roth A, Frotscher M, Jonas P (1997) Submillisecond AMPA receptor-mediated signaling at a principal neuron-interneuron synapse. Neuron 18:1009-1023.
25. Gentet LJ, Clements JD (2002) Binding site stoichiometry and the effects of phosphorylation on human alpha1 homomeric glycine receptors. J Physiol (Lond) 544:97-106.
26. A receptor-mediated responses in pyramidal cells of rat hippocampus. J Neurophysiol 69:1541-1555.
27. Hajos N, Katona I, Naiem SS, MacKie K, Ledent C, Mody I, Freund TF (2000) Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 12:3239-3249.
28. Hajos N, Ledent C, Freund TF (2001) Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106:1-4.
29. Hillard CJ, Wilkison DM, Edgemond WS, Campbell WB (1995) Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. Biochim Biophys Acta 1257:249-256.
30. Hoffman AF, Lupica CR (2000) Mechanisms of cannabinoid inhibition of GABAA synaptic transmission in the hippocampus. J Neurosci 20:2470-2479.
31. Jonas P, Bischofberger J, Sandkuhler J (1998) Corelease of two fast neurotransmitters at a central synapse. Science 281:419-424.
32. A chan- nel responses to brief agonist pulses. Neuron 15:181-191.
33. Jursky F, Nelson N (1995) Localization of glycine neurotransmitter transporter (GLYT2) reveals correlation with the distribution of glycine receptor. J Neurochem 64:1026-1033.
34. Kaila K, Voipio J (1987) Postsynaptic fall in intracellular pH induced by GABA-activated bicarbonate conductance. Nature 330:163-165.
35. + transient. J Neurosci 17:7662-7672.
36. Kirsch J, Wolters I, Triller A, Betz H (1993) Gephyrin antisense oligonucleotides prevent glycine receptor clustering in spinal neurons. Nature 366:745-748.
37. Kondratskaya EL, Lishko PV, Chatterjee SS, Krishtal OA (2002) BN52021, a platelet activating factor antagonist, is a selective blocker of glycine-gated chloride channel. Neurochem Int 40:647-653.
38. Kondratskaya EL, Fisyunov AI, Chatterjee SS, Krishtal OA (2004) Ginkgolide B preferentially blocks chloride channels formed by heteromeric glycine receptors in hippocampal pyramidal neurons of rat. Brain Res Bull 63:309-314.
39. Kreitzer AC, Regehr WG (2001) Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29:717-727.
40. Krishtal OA, Marchenko SM, Pidoplichko VI (1983) Receptor for ATP in the membrane of mammalian sensory neurones. Neurosci Lett 35:41-45.
41. Krishtal OA, Osipchuk Y, Vrublevsky SV (1988) Properties of glycine-activated conductances in rat brain neurones. Neurosci Lett 84:271-276.
42. Legendre P (1998) A reluctant gating mode of glycine receptor channels determines the time course of inhibitory miniature synaptic events in zebrafish hindbrain neurons. J Neurosci 18:2856-2870.
43. London M, Schreibman A, Hausser M, Larkum ME, Segev I (2002) The information efficacy of a synapse. Nat Neurosci 5:332-340.
44. Mahmoudian M (1997) The cannabinoid receptor: computer-aided molecular modeling and docking of ligand. J Mol Graph Model 15:149-153, 179.
45. Malosio ML, Marqueze-Pouey B, Kuhse J, Betz H (1991) Widespread expression of glycine receptor subunit mRNAs in the adult and developing rat brain. EMBO J 10:2401-2409.
46. Meyer G, Kirsch J, Betz H, Langosch D (1995) Identification of a gephyrin binding motif on the glycine receptor beta subunit. Neuron 15:563-572.
47. Misner DL, Sullivan JM (1999) Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J Neurosci 19:6795-6805.
48. Moss SJ, Smart TG (2001) Constructing inhibitory synapses. Nat Rev Neurosci 2:240-250.
49. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65.
50. O'Brien JA, Berger AJ (1999) Cotransmission of GABA and glycine to brain stem motoneurons. J Neurophysiol 82:1638-1641.
51. Ohno-Shosaku T, Maejima T, Kano M (2001) Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29:729-738.
52. Ranck JBJ (1973) Studies on single neurons in dorsal hippocampal formation and septum in unrestrained rats. I. Behavioral correlates and firing repertoires. Exp Neurol 41:461-531.
53. Seiler N, Sarhan S (1984) Synergistic anticonvulsant effects of a GABA agonist and glycine. Gen Pharmacol 15:367-369.
54. Shim JY, Welsh WJ, Hewlett AC (2003) Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction. Biopolymers 71:169-189.
55. Shirasaki T, Klee MR, Nakaye T, Akaike N (1991) Differential blockade of bicuculline and strychnine on GABA- and glycine-induced responses in dissociated rat hippocampal pyramidal cells. Brain Res 561:77-83.
56. Staley KJ, Soldo BL, Proctor WR (1995) Ionic mechanisms of neuronal excitation by inhibitory GABAA receptors. Science 269:977-981.
57. Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388:773-778.
58. A receptors in rat CA1 pyramidal neurons. J Neurophysiol 77:2213-2218.
59. Tao Q, McAllister SD, Andreassi J, Nowell KW, Cabral GA, Hurst DP, Bachtel K, Ekman MC, Reggio PH, Abood ME (1999) Role of a conserved lysine residue in the peripheral cannabinoid receptor (CB2): evidence for subtype specificity. Mol Pharmacol 55:605-613.
60. Taschenberger H, von Gersdorff H (2000) Fine-tuning an auditory synapse for speed and fidelity: developmental changes in presynaptic waveform, EPSC kinetics, and synaptic plasticity. J Neurosci 20:9162-9173.
61. Traub RD, Borck C, Colling SB, Jefferys JG (1996) On the structure of ictal events in vitro. Epilepsia 37:879-891.
62. Trussell LO (1997) Cellular mechanisms for preservation of timing in central auditory pathways. Curr Opin Neurobiol 7:487-492.
63. Tsou K, Brown S, Sanudo-Pena MC, MacKie K, Walker JM (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83:393-411.
64. Wang XJ, Buzsaki G (1996) Gamma oscillation by synaptic inhibition in a hippocarnpal interneuronal network model. J Neurosci 16:6402-6413.
65. Wang X-L, Rinzel J (1992) Alternating and synchronous rhythms in reciprocally inhibitory model neurons. Neural Comput 4:84-97.
66. Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocarnpal synapses. Nature 410:588-592.
67. Wilson PJ, Nicoll RA (2002) Endocannabinoid signaling in the brain. Science 296:678-682.
68. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D, Hogestatt ED (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400:452-457.
69. Zygmunt PM, Julius I, Di M, I, Hogestatt ED (2000) Anandamide-the other side of the coin. Trends Pharmacol Sci 21:43-44.